Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 6Esophageal Squamous Cell Carcinoma 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Medulloblastoma 1Locally Advanced Rectal Carcinoma 1High-Risk Cancer 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Cancer Metastatic 1Breast Cancer Invasive 1Adenocarcinoma Of Esophagus 1Adenocarcinoma 1

Interventions

Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × High-Risk Cancer × Neoadjuvant Therapy × Clear all
NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting
40 enrolled
Breast

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡